IKK mediates ischemia-induced neuronal death (original) (raw)

• Dirnagl, U., Iadecola, C. & Moskowitz, M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391–397 (1999).
  Article CAS Google Scholar
• Bergeron, M., Yu, A.Y., Solway, K.E., Semenza, G.L. & Sharp, F.R. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur. J. Neurosci. 11, 4159–4170 (1999).
  Article CAS Google Scholar
• Iadecola, C. et al. The transcription factor interferon regulatory factor 1 is expressed after cerebral ischemia and contributes to ischemic brain injury. J. Exp. Med. 189, 719–727 (1999).
  Article CAS Google Scholar
• Schneider, A. et al. NF-κB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5, 554–559 (1999).
  Article CAS Google Scholar
• Pizzi, M. et al. Opposing roles for NF-kappa B/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin-1beta. J. Biol. Chem. 277, 20717–20723 (2002).
  Article CAS Google Scholar
• Mattson, M.P. & Camandola, S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107, 247–254 (2001).
  Article CAS Google Scholar
• Qin, Z.H. et al. Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum. J. Neurosci. 19, 4023–4033 (1999).
  Article CAS Google Scholar
• Denk, A., Wirth, T. & Baumann, B. NF-kappaB transcription factors: critical regulators of hematopoiesis and neuronal survival. Cytokine Growth Factor Rev. 11, 303–320 (2000).
  Article CAS Google Scholar
• Hallenbeck, J.M. The many faces of tumor necrosis factor in stroke. Nat. Med. 8, 1363–1368 (2002).
  Article CAS Google Scholar
• Scholzke, M.N., Potrovita, I., Subramaniam, S., Prinz, S. & Schwaninger, M. Glutamate activates NF-kappaB through calpain in neurons. Eur. J. Neurosci. 18, 3305–3310 (2003).
  Article Google Scholar
• Bui, N.T., Livolsi, A., Peyron, J.F. & Prehn, J.H. Activation of nuclear factor kappaB and Bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IkappaBalpha. J. Cell Biol. 152, 753–764 (2001).
  Article CAS Google Scholar
• Karin, M., Yamamoto, Y. & Wang, Q.M. The IKK NF-kappa B system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3, 17–26 (2004).
  Article CAS Google Scholar
• Li, Q. & Verma, I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2, 725–734 (2002).
  Article CAS Google Scholar
• Hayden, M.S. & Ghosh, S. Signaling to NF-kappaB. Genes Dev. 18, 2195–2224 (2004).
  Article CAS Google Scholar
• Sakurai, H. et al. Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J. Biol. Chem. 278, 36916–36923 (2003).
  Article CAS Google Scholar
• Pasparakis, M. et al. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417, 861–866 (2002).
  Article CAS Google Scholar
• Minichiello, L. et al. Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 24, 401–414 (1999).
  Article CAS Google Scholar
• Tronche, F. et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23, 99–103 (1999).
  Article CAS Google Scholar
• Kaltschmidt, C., Kaltschmidt, B., Henkel, T., Stockinger, H. & P.A., B. Selective recognition of the activated form of transcription factor NF-κB by a monoclonal antibody. Biol. Chem. Hoppe-Seyler 376, 9–16 (1995).
  Article CAS Google Scholar
• Endres, M. et al. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J. Cereb. Blood Flow Metab. 18, 238–247 (1998).
  Article CAS Google Scholar
• Gabriel, C., Justicia, C., Camins, A. & Planas, A.M. Activation of nuclear factor-kappaB in the rat brain after transient focal ischemia. Brain Res. Mol. Brain Res. 65, 61–69 (1999).
  Article CAS Google Scholar
• Li, Q., Estepa, G., Memet, S., Israel, A. & Verma, I.M. Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation. Genes Dev. 14, 1729–1733 (2000).
  CAS PubMed PubMed Central Google Scholar
• Yin, M.J., Yamamoto, Y. & Gaynor, R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396, 77–80 (1998).
  Article CAS Google Scholar
• Vartiainen, N., Goldsteins, G., Keksa-Goldsteine, V., Chan, P.H. & Koistinaho, J. Aspirin inhibits p44/42 mitogen-activated protein kinase and is protective against hypoxia/reoxygenation neuronal damage. Stroke 34, 752–757 (2003).
  Article Google Scholar
• Burke, J.R. et al. BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. J. Biol. Chem. 278, 1450–1456 (2003).
  Article CAS Google Scholar
• Pieper, A.A., Verma, A., Zhang, J. & Snyder, S.H. Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol. Sci. 20, 171–181 (1999).
  Article CAS Google Scholar
• Bonventre, J.V. et al. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 390, 622–625 (1997).
  Article CAS Google Scholar
• Iadecola, C. et al. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc. Natl. Acad. Sci. USA 98, 1294–1299 (2001).
  Article CAS Google Scholar
• Kaltschmidt, C., Kaltschmidt, B., Neumann, H., Wekerle, H. & Baeuerle, P.A. Constitutive NF-κB activity in neurons. Mol. Cell. Biol. 14, 3981–3992 (1994).
  Article CAS Google Scholar
• Han, H.S., Karabiyikoglu, M., Kelly, S., Sobel, R.A. & Yenari, M.A. Mild hypothermia inhibits nuclear factor-kappaB translocation in experimental stroke. J. Cereb. Blood Flow Metab. 23, 589–598 (2003).
  Article CAS Google Scholar
• Song, Y.S., Lee, Y.S. & Chan, P.H. Oxidative stress transiently decreases the IKK complex (IKKα, β, and γ), an upstream component of NF-κB signaling, after transient focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 25, 1301–1311 (2005).
  Article CAS Google Scholar
• Khoshnan, A. et al. Activation of the IκB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity. J. Neurosci. 24, 7999–8008 (2004).
  Article CAS Google Scholar
• Zhang, W. et al. Neuronal activation of NF-κB contributes to cell death in cerebral ischemia. J. Cereb. Blood Flow Metab. 25, 30–40 (2005).
  Article Google Scholar
• Chen, L.W. et al. The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat. Med. 9, 575–581 (2003).
  Article CAS Google Scholar
• Luedde, T. et al. Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion-injury. J. Clin. Invest. 115, 849–859 (2005).
  Article CAS Google Scholar
• Staub, F. et al. Swelling, acidosis, and irreversible damage of glial cells from exposure to arachidonic acid in vitro. J. Cereb. Blood Flow Metab. 14, 1030–1039 (1994).
  Article CAS Google Scholar
• Aguirre, V. et al. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 277, 1531–1537 (2002).
  Article CAS Google Scholar
• Hu, M.C. et al. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117, 225–237 (2004).
  Article CAS Google Scholar
• Waterfield, M., Jin, W., Reiley, W., Zhang, M. & Sun, S.C. IkappaB kinase is an essential component of the Tpl2 signaling pathway. Mol. Cell. Biol. 24, 6040–6048 (2004).
  Article CAS Google Scholar
• Lamberti, C. et al. Regulation of beta-catenin function by the IkappaB kinases. J. Biol. Chem. 276, 42276–42286 (2001).
  Article CAS Google Scholar
• Nurmi, A. et al. Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke 35, 987–991 (2004).
  Article Google Scholar
• Williams, A.J. et al. Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factor-kappaB activation, gliosis, and leukocyte infiltration. J. Cereb. Blood Flow Metab. 23, 75–87 (2003).
  Article CAS Google Scholar
• Chan, P.H. et al. Brain infarction is not reduced in SOD-1 transgenic mice after a permanent focal cerebral ischemia. Neuroreport 5, 293–296 (1993).
  Article CAS Google Scholar
• Azoitei, N., Wirth, T. & Baumann, B. Activation of the IκB kinase complex is sufficient for neuronal differentiation of PC12 cells. J. Neurochem. 93, 1487–1501 (2005).
  Article CAS Google Scholar
• Yamaoka, S. et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 93, 1231–1240 (1998).
  Article CAS Google Scholar
• Ma, J., Qiu, J., Hirt, L., Dalkara, T. & Moskowitz, M.A. Synergistic protective effect of caspase inhibitors and bFGF against brain injury induced by transient focal ischaemia. Br. J. Pharmacol. 133, 345–350 (2001).
  Article CAS Google Scholar
• Maier, H.J., Marienfeld, R., Wirth, T. & Baumann, B. Critical role of RelB serine 368 for dimerization and p100 stabilization. J. Biol. Chem. 278, 39242–39250 (2003).
  Article CAS Google Scholar
• Wang, X. et al. Inhibition of tumor necrosis factor-alpha-converting enzyme by a selective antagonist protects brain from focal ischemic injury in rats. Mol. Pharmacol. 65, 890–896 (2004).
  Article CAS Google Scholar